Colorectal cancer continues to be third leading cause of cancer death among both men and women in the United States. The prognosis is often dependent on stage of disease that is, a small intestinal polyp carries a better prognosis than a large mass. CRC testing, by fecal occult blood test (FOBT) or endoscopic examination, has been shown to improve prognosis by detecting disease earlier. That's why many health groups recommend CRC screening for men and women over 50 years old. Nevertheless, studies show well under half of Americans 50 and over are getting screened, and disparities are often seen based on race, education and healthcare access.
The study was part of a set of UCLA Center for Health Policy Research studies on cancer screening led by Ninez Ponce, Ph.D., M.P.P., and funded by the National Cancer Institute and The California Endowment. Lead author David Etzioni, M.D., M.S.H.S. of the UCLA School of Medicine and his colleagues used the 2001 California Health Interview Survey1 to investigate the CRC screening habits of 22,343 adults aged 50 and older in California. Their goal was to determine rates of CRC screening, predictors of screening, and reasons why people chose not to undergo CRC screening.
Approximately 54 percent had a recent CRC test, well above the national average. However, two groups appeared less likely to be screened. Latinos,
'"/>
Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
25-Oct-2004